BSE Live
Dec 29, 16:01Prev. Close
1101.45
Open Price
1101.45
Bid Price (Qty.)
1136.30 (192)
Offer Price (Qty.)
1150.00 (4)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Profit & Loss account of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 138.68 | 165.15 | 136.83 | 95.32 | 75.87 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 138.68 | 165.15 | 136.83 | 95.32 | 75.87 | |
| Total Operating Revenues | 138.68 | 165.15 | 136.83 | 95.32 | 75.87 | |
| Other Income | 3.92 | 0.93 | 1.10 | 1.52 | 0.55 | |
| Total Revenue | 142.60 | 166.08 | 137.93 | 96.84 | 76.42 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 91.92 | 114.06 | 103.73 | 71.84 | 57.43 | |
| Purchase Of Stock-In Trade | 0.67 | 0.13 | 0.26 | 0.36 | 0.05 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -5.52 | 5.15 | -2.71 | -2.56 | 0.40 | |
| Employee Benefit Expenses | 11.69 | 8.43 | 5.53 | 4.15 | 2.55 | |
| Finance Costs | 2.50 | 2.21 | 2.18 | 1.88 | 1.19 | |
| Depreciation And Amortisation Expenses | 4.39 | 3.06 | 2.86 | 2.37 | 1.69 | |
| Other Expenses | 25.81 | 22.14 | 18.52 | 12.99 | 10.03 | |
| Total Expenses | 131.46 | 155.18 | 130.38 | 91.03 | 73.34 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 11.14 | 10.90 | 7.55 | 5.81 | 3.08 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 11.14 | 10.90 | 7.55 | 5.81 | 3.08 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 3.00 | 3.30 | 3.06 | 2.42 | 1.26 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.32 | -0.09 | -0.19 | -0.05 | -0.07 | |
| Tax For Earlier Years | 0.03 | 0.14 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 2.71 | 3.35 | 2.87 | 2.37 | 1.19 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 8.43 | 7.55 | 4.68 | 3.44 | 1.89 | |
| Profit/Loss From Continuing Operations | 8.43 | 7.55 | 4.68 | 3.44 | 1.89 | |
| Profit/Loss For The Period | 8.43 | 7.55 | 4.68 | 3.44 | 1.89 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 8.13 | 7.27 | 4.51 | 6.70 | 4.14 | |
| Diluted EPS (Rs.) | 8.13 | 7.27 | 4.51 | 6.70 | 4.14 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 9.92 | 7.54 | 4.26 | 1.26 | 0.00 | |
| Indigenous Raw Materials | 88.32 | 106.52 | 99.48 | 70.58 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.31 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 6.00 | 0.00 |
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y